Hayakawa N, Kikuchi E, Mizuno R, Oya M. The role of programmed cell death-1 positivity in tumor nest on clinical outcome in upper tract urothelial carcinoma patients treated with radical nephroureterectomy. EMUC 2017, O3.
Adjuvant atezolizumab versus placebo bij patiënten met niercelcarcinoom en hoog recidiefrisico
jan 2023 | Immuuntherapie, Uro-oncologie